MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/da.23242

Медицинская библиотека · Depression and anxiety · 2022

Efficacy of D-cycloserine augmented brief intensive cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised clinical trial.

Farrell Lara J, Waters Allison M, Tiralongo Evelin, Mathieu Sharna, McKenzie Matthew, Garbharran Vinay, Ware Robert S, Zimmer-Gembeck Melanie J, McConnell Harry, Lavell Cassie, Cadman Jacinda, Ollendick Thomas H, Hudson Jennifer L, Rapee Ronald M, McDermott Brett, Geller Daniel, Storch Eric A

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To examine the efficacy of weight-adjusted D-cycloserine (DCS) (35 or 70 mg) relative to placebo augmentation of intensive exposure therapy for youth with obsessive-compulsive disorder (OCD) in a double-blind, randomised controlled trial, and examine whether antidepressant medication or patient age moderated outcomes.

METHODS

Youth (n = 100, 7-17 years) with OCD were randomised in a 1:1 ratio to either DCS + exposure (n = 49) or placebo + exposure (n = 51). Assessments occurred posttreatment, 1 month later, and at 3 and 6 months. Pills were ingested immediately before sessions.

RESULTS

Significant improvements on all outcomes were observed at posttreatment, and to 6-month follow-up. Treatment arms did not differ across time, with no significant time-by-medication interactions on symptom severity (T1 to T2 estimate: 9.3, 95% confidence interval [CI]: -11.2 to -7.4, and estimate -10.7, 95% CI: -12.6 to -8.7), diagnostic severity (T1 to T2 estimate: -2.0, 95% CI: -2.4 to -1.5 and estimate -2.5, 95% CI: -3.0 to -2.0) or global functioning (T1 to T2 estimate: 13.8, 95% CI: 10.6 to 17.0, and estimate 16.6, 95% CI: 13.2 to 19.9). Neither antidepressants at baseline nor age moderated primary outcomes. There were significantly fewer responders/remitters at 1- and 6-month follow-up among youth in the DCS condition stabilised on SSRIs, relative to youth not taking SSRIs.

CONCLUSIONS

DCS augmented intensive exposure therapy did not result in overall additional benefits relative to placebo. Intensive exposure proved effective in reducing symptoms for the overall sample.

Для цитирования: Farrell Lara J, Waters Allison M, Tiralongo Evelin, Mathieu Sharna, McKenzie Matthew, Garbharran Vinay, Ware Robert S, Zimmer-Gembeck Melanie J, McConnell Harry, Lavell Cassie, Cadman Jacinda, Ollendick Thomas H, Hudson Jennifer L, Rapee Ronald M, McDermott Brett, Geller Daniel, Storch Eric A. Efficacy of D-cycloserine augmented brief intensive cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised clinical trial.. Depression and anxiety. 2022. DOI: 10.1002/da.23242.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.